Effect of melatonin and misoprostol on bacterial translocation in portal hypertensive rats

Ömer Topuz1, Yavuz Selim Ilhan, Osman Doğru

  • 1Department of General Surgery, Kayseri Training and Research Hospital, Kayseri, Turkey. drotopuz@yahoo.com

Abstract

Insights

Melatonin and misoprostol effectively reduced bacterial translocation in rats with portal hypertension. This finding is crucial for managing complications associated with liver cirrhosis.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Pharmacology

Background:

  • Portal hypertension, a major complication of cirrhosis, significantly increases morbidity and mortality.
  • Bacterial translocation is a key factor exacerbating these outcomes in portal hypertension patients.

Purpose of the Study:

  • To investigate the therapeutic potential of melatonin and misoprostol.
  • To determine the efficacy of these agents in mitigating bacterial translocation induced by portal hypertension.

Main Methods:

  • A rat model of portal hypertension was established using portal vein ligation.
  • Animals received melatonin or misoprostol for 3 days post-surgery.
  • Bacterial translocation was assessed via microbial cultures, PCR, and histopathological examination of mesenteric lymph nodes, blood, and ileum.

Main Results:

  • Control rats exhibited significant bacterial translocation, confirmed by positive cultures and PCR.
  • Histopathological analysis revealed reduced edema, vasodilation, and inflammation in treatment groups compared to controls.
  • Melatonin and misoprostol treatment groups demonstrated a decreased incidence of bacterial translocation.

Conclusions:

  • Bacterial translocation is a significant issue in experimental portal hypertension.
  • Melatonin and misoprostol show promise in reducing bacterial translocation in portal hypertensive conditions.

Related Concept Videos